Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Marco D DiBonaventura"'
Autor:
Joseph C Cappelleri, Matthew J Brookes, Natalie Bohm, John Waller, Irene Modesto, Marco D DiBonaventura, Ruth Mokgokong, Olivia Massey, Robert Wood, Danielle Bargo
Publikováno v:
BMJ Open Gastroenterology, Vol 7, Iss 1 (2020)
Objective Ulcerative colitis (UC) is a lifelong, relapsing-remitting disease. Patients non-responsive to pharmacological treatment may require a colectomy. We estimated pre-colectomy and post-colectomy healthcare resource utilisation (HCRU) and costs
Externí odkaz:
https://doaj.org/article/c5d9c17e64254fdcb9025b0823da3aa2
Autor:
Aaron Yarlas, Stephen Maher, Martha Bayliss, Andrew Lovley, Joseph C. Cappelleri, Andrew G. Bushmakin, Marco D. DiBonaventura
Publikováno v:
Journal of Patient-Centered Research and Reviews, Vol 7, Iss 2, Pp 189-205 (2020)
Purpose: The 32-item Inflammatory Bowel Disease Questionnaire (IBDQ-32) is the most frequently used instrument to capture disease-specific quality of life in randomized clinical trials for ulcerative colitis. This review and meta-analysis provides th
Externí odkaz:
https://doaj.org/article/327625e280bc446bbf768cf9a05d8f0a
Autor:
Aaron Yarlas, Stephen M. Maher, Martha S. Bayliss, Andrew Lovley, Joseph C. Cappelleri, Marco D. DiBonaventura
Publikováno v:
Journal of Patient-Reported Outcomes, Vol 2, Iss 1, Pp 1-12 (2018)
Abstract Patients with ulcerative colitis, a type of inflammatory bowel disease, report negative impacts of disease symptoms on work-related outcomes, including absenteeism and presenteeism. As a way to better understand the impact of this disease an
Externí odkaz:
https://doaj.org/article/1f4891916654409989d1d0854d75f58d
Autor:
Marco d. DiBonaventura, Danielle Bargo, James Lucas, Daniel Bluff, Ben Hoskin, Joseph C. Cappelleri, Cem Kayhan, Leonardo Salese
Publikováno v:
Gastroenterology. 156:S-441
Autor:
Joyce LaMori, Hilary J Gross, Aarti A Patel, Melanie Crain, Marco D DiBonaventura, Samir H Mody, Jeff R Schein
Publikováno v:
Circulation: Cardiovascular Quality and Outcomes. 4
Objective: Atrial fibrillation (AF) may manifest with comorbidities. We examined the prevalence of comorbidities and general medication use among AF patients in order to assess total disease burden. Methods: Data were obtained from the 2009 National